罕见病的公平、获取和经济评价

{"title":"罕见病的公平、获取和经济评价","authors":"N. Bosanquet, G. Domenighetti, A. Beresniak, J. Auray, L. Crivelli, L. Richard, Paul Howard","doi":"10.1007/BF03257374","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":88631,"journal":{"name":"Pharmaceutical development and regulation","volume":"1 1","pages":"151-157"},"PeriodicalIF":0.0000,"publicationDate":"2003-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03257374","citationCount":"15","resultStr":"{\"title\":\"Equity, Access and Economic Evaluation in Rare Diseases\",\"authors\":\"N. Bosanquet, G. Domenighetti, A. Beresniak, J. Auray, L. Crivelli, L. Richard, Paul Howard\",\"doi\":\"10.1007/BF03257374\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":88631,\"journal\":{\"name\":\"Pharmaceutical development and regulation\",\"volume\":\"1 1\",\"pages\":\"151-157\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2003-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/BF03257374\",\"citationCount\":\"15\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutical development and regulation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/BF03257374\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical development and regulation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF03257374","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}